Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors-Reference-Cited by-同舟云学术

Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors

Published:2017-08-09 Issue:22 Volume:12 Page:1873-1881
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Amata Emanuele¹^ORCID,Marrazzo Agostino¹,Dichiara Maria¹,Modica Maria N.¹,Salerno Loredana¹,Prezzavento Orazio¹,Nastasi Giovanni²,Rescifina Antonio¹,Romeo Giuseppe¹,Pittalà Valeria¹

Affiliation:

1. Department of Drug Sciences; University of Catania; Viale A. Doria 6 95125 Catania Italy

2. Department of Mathematics and Computer Sciences; University of Catania; Viale A. Doria 6 95125 Catania Italy

Funder

Università di Catania

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference63 articles.

1. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.

2. Pharmacological and Clinical Aspects of Heme Oxygenase

3. The structure, organization and differential expression of the gene encoding rat heme oxygenase-2

4. The human 32-kDa stress protein induced by exposure to arsenite and cadmium ions is heme oxygenase

5. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Acetamide-Based HO-1 Inhibitor Counteracts Glioblastoma Progression by Interfering with the Hypoxic–Angiogenic Pathway;International Journal of Molecular Sciences;2024-05-15

2. Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer;ACS Medicinal Chemistry Letters;2024-04-30

3. Enzyme Databases in the Era of Omics and Artificial Intelligence;International Journal of Molecular Sciences;2023-11-29

4. Heme Oxygenase-1 Overexpression Promotes Uveal Melanoma Progression and Is Associated with Poor Clinical Outcomes;Antioxidants;2022-10-08

5. Meet the Editorial Board Member;Mini-Reviews in Medicinal Chemistry;2022-08